Kukje Pharma Co Ltd (002720) - Total Liabilities

Latest as of September 2025: ₩84.80 Billion KRW ≈ $57.47 Million USD

Based on the latest financial reports, Kukje Pharma Co Ltd (002720) has total liabilities worth ₩84.80 Billion KRW (≈ $57.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Kukje Pharma Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Kukje Pharma Co Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Kukje Pharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Kukje Pharma Co Ltd total assets.

Kukje Pharma Co Ltd Competitors by Total Liabilities

The table below lists competitors of Kukje Pharma Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Matang Bhd KLSE:0189	Malaysia	RM6.72 Million
Kandi Technologies Group Inc NASDAQ:KNDI	USA	$87.39 Million
Gielda Praw Majatkowych Vindexus S.A. WAR:VIN	Poland	zł148.84 Million
Vishnu Prakash R Punglia Limited NSE:VPRPL	India	Rs12.39 Billion
Marathon Bancorp, Inc. Common Stock NASDAQ:MBBC	USA	$201.49 Million
Arianne Phosphate Inc V:DAN	Canada	CA$46.27 Million
Asian Pac Holdings Bhd KLSE:4057	Malaysia	RM1.15 Billion
Korea Steel Co Ltd KO:007280	Korea	₩359.31 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Kukje Pharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 002720 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.19	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.89	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.47	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kukje Pharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kukje Pharma Co Ltd (2011–2024)

The table below shows the annual total liabilities of Kukje Pharma Co Ltd from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩76.00 Billion ≈ $51.50 Million	-2.95%
2023-12-31	₩78.31 Billion ≈ $53.07 Million	+25.27%
2022-12-31	₩62.51 Billion ≈ $42.36 Million	-12.19%
2021-12-31	₩71.20 Billion ≈ $48.25 Million	-5.23%
2020-12-31	₩75.13 Billion ≈ $50.91 Million	+2.02%
2019-12-31	₩73.64 Billion ≈ $49.90 Million	+27.99%
2018-12-31	₩57.54 Billion ≈ $38.99 Million	-9.91%
2017-12-31	₩63.87 Billion ≈ $43.28 Million	+3.12%
2016-12-31	₩61.94 Billion ≈ $41.97 Million	-9.16%
2015-12-31	₩68.18 Billion ≈ $46.21 Million	+2.29%
2014-12-31	₩66.66 Billion ≈ $45.17 Million	+12.78%
2013-12-31	₩59.10 Billion ≈ $40.05 Million	-0.79%
2012-12-31	₩59.57 Billion ≈ $40.37 Million	-10.85%
2011-12-31	₩66.82 Billion ≈ $45.28 Million	--

About Kukje Pharma Co Ltd

KO:002720 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$44.92 Million

₩66.28 Billion KRW

Market Cap Rank

#22387 Global

#1427 in Korea

Share Price

₩3255.00

Change (1 day)

+0.15%

52-Week Range

₩3045.00 - ₩5230.00

All Time High

₩12612.03